NYSE:TXMD

Therapeuticsmd Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy TXMD

*Your capital is at risk

$1.97

-0.0700 (-3.43%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

TXMD Prediction Chart

TXMD Predictions History

Latest community submissions for TXMD.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Aug 17, 2022	$9.81 +2.29%	$10.20	V	96.18%	1
dobryant029.333133	Aug 17, 2022	Bullish	$10.20	V	—	1
JS Pro	Jul 29, 2022	$6.29 +4.83%	$6.23	V	99.04%	2
dobryant029.333133	Jul 29, 2022	Bullish	$6.23	V	—	1
JS Pro	Jul 5, 2022	$9.95 -0.10%	$10.00	X	99.50%	3
AlexVel Pro	Jul 5, 2022	$9.95 -0.13%	$10.00	X	99.47%	3
JS Pro	Nov 3, 2021	$0.742 -98.07%	$0.769	V	96.48%	0
avlanih	Nov 3, 2021	$0.92 -97.61%	$0.769	X	80.38%	1
JS Pro	Oct 20, 2021	$0.795 -97.99%	$0.790	X	99.38%	4
AlexVel Pro	Oct 20, 2021	$0.80 -97.97%	$0.790	X	98.75%	2

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TXMD with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT THERAPEUTICSMD INC

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alon...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by